Home > HSE data management and performance profile reports July - September 2024.

Health Service Executive. (2025) HSE data management and performance profile reports July - September 2024. Dublin: Health Service Executive.

[img]
Preview
PDF (Performance profile July – September 2024)
1MB
[img]
Preview
PDF (Management data report - September 2024)
1MB
[img]
Preview
PDF (Management data report - August 2024)
3MB
[img]
Preview
PDF (Management data report - July 2024)
2MB

Performance Profile July – September 2024
P.16 Substance use                 
KPI SI25 % of substance users (under 18 years) for whom treatment has commenced within one week following assessment
S122 % of substance users (over 18 years) for whom treatment has commenced within one calendar month following assessment 

P.23 Social inclusion
Performance area - % of substance users (over 18 years) for whom treatment has commenced within one calendar month following assessment-SI22
%. of substance users (under 18 years) for whom treatment has commenced within one week following assessment-SI25
Figures - % access to substance users treatment (>18 years); % access to substance users treatment (<18 years). 

P.8 Health and wellbeing
No. of smokers who received face to face or telephone intensive cessation support from a cessation counsellor – HWB27
% of smokers on cessation programmes who were quit at four weeks – HWB26 

Management data report – September 2024
p.120 Social Inclusion
Opioid Agonist Treatment
SI1 Total no. of clients in receipt of opioid agonist treatment (outside prisons)
SI13 Average waiting time from referral to assessment for opioid agonist treatment (days)
SI14 Average waiting time from opioid agonist assessment to exit from waiting list or treatment commenced (days)

P.120 Needle Exchange
S148 No of unique individuals attending the Pharmacy Needle Exchange Programme

P.123 Substance Use
S121 No. of substance users (over 18) for whom treatment has commenced within one calendar month following assessment
S122 % of substance users (over 18 years) for whom treatment has commenced within one calendar month following assessment
S124 No. of substance users (under 18 years) for whom treatment has commenced within one week following assessment
S125 % of substance users (under 18 years) for whom treatment has commenced within one week following assessment

Alcohol Use
S135 No. of problem alcohol users (over 18 years) for whom treatment has commenced within one calendar month following assessment
S138 % of problem alcohol users (over 18 years) for whom treatment has commenced within one calendar month following assessment
S138 No. of problem alcohol users (under 18 years) for whom treatment has commenced within one week following assessment
S139 % of problem alcohol users (under 18 years) for whom treatment has commenced within one week following assessment

P.142 Environmental Health
HWB29 No. of initial tobacco sales and/or nicotine inhaling product sales to minors test purchase inspections carried out
SHB83 No. of inspections of e-cigarette and refill container manufacturers, importers, distributors and retailers under the E.U. (Manufacture, Presentation and Sale of Tobacco and Related Products) Regulations 2016

P108 Tobacco
HWB27 No. of smokers who received face to face or telephone intensive cessation support from a cessation counsellor.
HWB101 No. of smokers who are receiving online cessation support services
HWB26 % of smokers on cessation programmes who were quit at four weeks

Item Type
Report
Publication Type
Irish-related, Report
Drug Type
All substances, Opioid, Tobacco / Nicotine
Intervention Type
Treatment method, Harm reduction, Policy
Date
May 2025
Publisher
Health Service Executive
Corporate Creators
Health Service Executive
Place of Publication
Dublin
EndNote
Related (external) link
Subjects
B Substances > Substances in general
B Substances > Alcohol
B Substances > Tobacco (cigarette smoking)
B Substances > Tobacco (cigarette smoking) > Nicotine product (e-cigarette / vaping / heated)
B Substances > Opioids (opiates)
G Health and disease > Disease by cause (Aetiology) > Needle (sharing / injecting)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
HJ Treatment or recovery method > Substance disorder treatment method > Cessation of tobacco / nicotine use
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Needle syringe distribution and exchange
J Health care, prevention, harm reduction and treatment > Health care delivery
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility
J Health care, prevention, harm reduction and treatment > Health care administration > Health care quality control
L Social psychology and related concepts > Social inclusion and exclusion
L Social psychology and related concepts > Waiting for a product or service
MA-ML Social science, culture and community > Social condition > Homelessness > Homeless services
T Demographic characteristics > Adolescent / youth (teenager / young person)
T Demographic characteristics > Adult
T Demographic characteristics > Homeless person
VA Geographic area > Europe > Ireland
VA Geographic area > Europe > Ireland > County / regional data

Repository Staff Only: item control page